Nektar Therapeutics today announced that new Phase 2 clinical data from its study of single-agent NKTR-102 in metastatic breast cancer patients will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas on December 12, 2010.
More...